Latest Reimbursement News

The Star Entertainment Group has terminated its binding Heads of Agreement with joint venture partners over Brisbane and Gold Coast developments, retaining its assets but incurring significant repayment and reimbursement obligations.

Advanced Health Intelligence Ltd has locked in up to AUD 5.5 million from Oakley Capital Partners, reinforcing its capital base as it pushes toward reinstatement on the ASX and broader growth ambitions.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Gibb River Diamonds has secured a contract mining agreement for its Edjudina Gold Project, aiming to start open pit mining at the Neta Prospect by August 2025, subject to permit approvals. The deal minimizes financial risk while positioning the company to capitalise on gold production.

Solara Minerals has strengthened its foothold in Western Australia’s gold and copper sector through a major project acquisition and key executive appointments, setting the stage for upcoming drilling campaigns.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

ImpediMed Limited reported a record quarter for its SOZO device sales with $6.3 million in contracts, supported by expanded US reimbursement coverage and new funding. Despite stable revenue, the company’s cost-cutting and strategic moves position it well for growth in FY26.

The Star Entertainment Group reported steady Q4 FY25 revenue of $270 million but widened its EBITDA loss to $27 million, reflecting ongoing regulatory pressures and operational challenges. The company secured $233 million from strategic investors Bally’s Corporation and Investment Holdings, while negotiations continue over its Brisbane joint venture exit.

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.

Hot Chili Limited confirms a significant copper-gold mineralisation footprint at its La Verde discovery in Chile, completing phase-one drilling and advancing strategic funding discussions for its key projects.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 alongside continued cash flow improvements.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.